aminopterin has been researched along with Multiple Myeloma in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (62.50) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (25.00) | 29.6817 |
| 2010's | 1 (12.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Berube, C; Coutré, SE; Dinner, S; Dunn, TJ; Gotlib, J; Hao, Y; Liedtke, M; Medeiros, BC; Price, E | 1 |
| Crowe, JE; House, FS; McGraw, PA; Yu, X | 1 |
| BARTLETT, GR; MARLOW, AA | 1 |
| ANDERSON, RE; MORROW, LB | 1 |
| Cho, YJ; Choi, Y; Chung, YH; Paik, DJ; Youn, J | 1 |
| Myoken, Y; Okamoto, T; Osaki, T; Sato, GH; Sato, JD; Takada, K; Yabumoto, M | 1 |
| Björklund, G; Jernberg, H; Nilsson, K | 1 |
| Matsuya, Y; Takada, M; Yabe, N; Yamane, I | 1 |
1 trial(s) available for aminopterin and Multiple Myeloma
| Article | Year |
|---|---|
A phase 1, open-label, dose-escalation study of pralatrexate in combination with bortezomib in patients with relapsed/refractory multiple myeloma.
Topics: Aged; Aminopterin; Antineoplastic Combined Chemotherapy Protocols; Bortezomib; Dose-Response Relationship, Drug; Female; Humans; Infusions, Intravenous; Male; Maximum Tolerated Dose; Middle Aged; Multiple Myeloma; Neoplasm Recurrence, Local; Treatment Outcome | 2016 |
7 other study(ies) available for aminopterin and Multiple Myeloma
| Article | Year |
|---|---|
An optimized electrofusion-based protocol for generating virus-specific human monoclonal antibodies.
Topics: Aminopterin; Antibodies, Monoclonal; Antibodies, Viral; B-Lymphocytes; Cell Fusion; Cell Line, Tumor; Cell Transformation, Viral; Coculture Techniques; Herpesvirus 4, Human; Humans; Hybridomas; Hypoxanthine; Immunoglobulin G; Influenza A Virus, H3N2 Subtype; Multiple Myeloma; Oligodeoxyribonucleotides; Ouabain; Respiratory Syncytial Virus, Human; Thymidine | 2008 |
New therapy for leukemia, polycythemia, and lymphoma.
Topics: Aminopterin; Chronic Disease; Hodgkin Disease; Humans; Leukemia; Lymphoma; Mechlorethamine; Multiple Myeloma; Neoplasms; Phlebotomy; Polycythemia; Triethylenemelamine; Urethane; X-Ray Therapy | 1953 |
ACTIVE TUBERCULOSIS IN LEUKEMIA. MALIGNANT LYMPHOMA AND MYELOFIBROSIS.
Topics: Alkylating Agents; Aminopterin; Busulfan; Hodgkin Disease; Humans; Leukemia; Leukemia, Lymphoid; Leukemia, Myeloid; Lymphoma; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Mechlorethamine; Mercaptopurine; Methotrexate; Multiple Myeloma; Neoplasms; Pathology; Primary Myelofibrosis; Sarcoma; Triethylenemelamine; Tuberculosis; Tuberculosis, Pulmonary; Urethane | 1965 |
Requirement of de novo protein synthesis for aminopterin-induced apoptosis in a mouse myeloma cell line.
Topics: Aminopterin; Animals; Apoptosis; Cycloheximide; Dactinomycin; DNA Fragmentation; Genes, myc; Hypoxanthine Phosphoribosyltransferase; Mice; Multiple Myeloma; Nucleic Acid Synthesis Inhibitors; Protein Biosynthesis; Protein Synthesis Inhibitors; RNA; Transcription, Genetic; Tumor Cells, Cultured | 2001 |
An alternative method for the isolation of NS-1 hybridomas using cholesterol auxotrophy of NS-1 mouse myeloma cells.
Topics: Aminopterin; Animals; Cell Line; Cell Separation; Cell Transformation, Neoplastic; Cholesterol; Culture Media; Hybridomas; Hypoxanthines; Mice; Mice, Inbred BALB C; Multiple Myeloma; Thymidine; Tumor Cells, Cultured | 1989 |
Establishment of a new human myeloma cell line (U-2030) and selection of a hat-sensitive subline.
Topics: Aminopterin; Antigens, Surface; Antineoplastic Combined Chemotherapy Protocols; Cell Line; Drug Resistance; Humans; Hypoxanthine; Hypoxanthines; Immunoglobulins; Multiple Myeloma; Thymidine | 1987 |
Enhanced formation of mouse hybridomas without hat treatment in a serum-free medium.
Topics: Aminopterin; Animals; Cell Division; Cell Fusion; Cell Line; Culture Media; Humans; Hybridomas; Hypoxanthine; Hypoxanthines; Mice; Multiple Myeloma; Spleen; Thymidine | 1986 |